KPIs & Operating Metrics(New)
Growth Metrics

Amgen (AMGN) Cash from Operations (2016 - 2025)

Amgen (AMGN) has 17 years of Cash from Operations data on record, last reported at 1603000000.0 in Q4 2025.

  • For Q4 2025, Cash from Operations fell 66.4% year-over-year to 1603000000.0; the TTM value through Dec 2025 reached 9958000000.0, down 13.33%, while the annual FY2025 figure was 9958000000.0, 13.33% down from the prior year.
  • Cash from Operations reached 1603000000.0 in Q4 2025 per AMGN's latest filing, down from 4684000000.0 in the prior quarter.
  • Across five years, Cash from Operations topped out at 4771000000.0 in Q4 2024 and bottomed at 538000000.0 in Q4 2023.
  • Average Cash from Operations over 5 years is 2445050000.0, with a median of 2349000000.0 recorded in 2021.
  • Peak YoY movement for Cash from Operations: crashed 79.69% in 2023, then skyrocketed 786.8% in 2024.
  • A 5-year view of Cash from Operations shows it stood at 2808000000.0 in 2021, then decreased by 5.66% to 2649000000.0 in 2022, then plummeted by 79.69% to 538000000.0 in 2023, then surged by 786.8% to 4771000000.0 in 2024, then plummeted by 66.4% to 1603000000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Cash from Operations were 1603000000.0 in Q4 2025, 4684000000.0 in Q3 2025, and 2280000000.0 in Q2 2025.